Workflow
furmonertinib
icon
Search documents
ArriVent BioPharma(AVBP) - Prospectus(update)
2024-01-23 22:18
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 23, 2024. Registration No. 333-276397 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ARRIVENT BIOPHARMA, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Classification Code Number) 86-3336099 (I.R.S. Emp ...
ArriVent BioPharma(AVBP) - Prospectus(update)
2024-01-22 11:35
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 22, 2024. Registration No. 333-276397 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ARRIVENT BIOPHARMA, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Classification Code Number) 86-3336099 (I.R.S. Emp ...
ArriVent BioPharma(AVBP) - Prospectus
2024-01-05 21:16
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 5, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ARRIVENT BIOPHARMA, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Classification Code Number) 86-3336099 (I.R.S. Employer Identification Numbe ...